| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXSL2000230 | BIVV020注射液 | riliprubart | Injection | Biological Products(1) | Import Drug Application | 2020-12-16 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Recherche & Developpement | In Review | 2020-12-15 | view |